Invention Grant
- Patent Title: Splice-region antisense composition and method
-
Application No.: US13219409Application Date: 2011-08-26
-
Publication No.: US08436163B2Publication Date: 2013-05-07
- Inventor: Patrick L. Iversen , Robert Hudziak
- Applicant: Patrick L. Iversen , Robert Hudziak
- Applicant Address: US OR Corvallis
- Assignee: AVI BioPharma, Inc.
- Current Assignee: AVI BioPharma, Inc.
- Current Assignee Address: US OR Corvallis
- Agency: Seed IP Law Group PLLC
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C07H21/02 ; A61K48/00

Abstract:
Antisense compositions targeted against an mRNA sequence coding for a selected protein, at a region having its 5′ end from 1 to about 25 base pairs downstream of a normal splice acceptor junction in the preprocessed mRNA, are disclosed. The antisense compound is RNase-inactive, and is preferably a phosphorodiamidate-linked morpholino oligonucleotide. Such targeting is effective to inhibit natural mRNA splice processing, produce splice variant mRNAs, and inhibit normal expression of the protein.
Public/Granted literature
- US20120053228A1 SPLICE-REGION ANTISENSE COMPOSITION AND METHOD Public/Granted day:2012-03-01
Information query